Challenges in implementing genomic medicine: The mayo clinic center for individualized medicine

Clinical Pharmacology and Therapeutics

Volumn 94, Issue 2, 2013, Pages 204-206

  Farrugia, G ^a   Weinshilboum, R M ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CARBAMAZEPINE; MERCAPTOPURINE; PEGINTERFERON; RIBAVIRIN;

ARTICLE; BIOETHICS; BIOINFORMATICS; BREAST CANCER; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DECISION SUPPORT SYSTEM; DNA SEQUENCE; ELECTRONIC MEDICAL RECORD; EPIGENETICS; EXOME; FOOD AND DRUG ADMINISTRATION; GENOTYPE; HUMAN; MEDICAL PRACTICE; MICROBIOME; NATIONAL HEALTH ORGANIZATION; PATIENT CARE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PHENOTYPE; PILOT STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BIOLOGICAL MARKERS; ELECTRONIC HEALTH RECORDS; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; PHARMACOGENETICS;

EID: 84880706320     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.52     Document Type: Article

References (4)

1. Weinshilboum, R.M. The Gordon Wilson Lecture. The Mayo model: one path to an academic medical center. Trans. Am. Clin. Climatol. Assoc. 113, 91-103; discussion 103 (2002).
2. Kitzmiller, J.P. et al. Program in pharmacogenomics at the Ohio State University Medical Center. Pharmacogenomics 13, 751-756 (2012).
3. Pulley, J.M. et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin. Pharmacol. Ther. 92, 87-95 (2012).
4. Pereira, N.L. & Weinshilboum, R.M. The impact of pharmacogenomics on the management of cardiac disease. Clin. Pharmacol. Ther. 90, 493-495 (2011).